Hansen, Christian Rønn, et al. “Eliminating the High-Risk CTV1 Margin in DAHANCA Oropharyngeal Radiotherapy: Dosimetric Impact on Dysphagia and Organ-at-Risk Doses”. Acta Oncologica, vol. 64, Sept. 2025, pp. 1205-11, doi:10.2340/1651-226X.2025.44049.